logo
Share SHARE
FONT-SIZE Plus   Neg

Medgenics Q1 Loss Widens - Quick Facts

Medgenics Inc. (MDGN) posted first-quarter net loss of $2.71 million or $0.28 per share, wider than $0.34 million or $0.06 per share in the previous year period.

General and administrative expense for the first quarter increased to $1.36 million from $0.78 million in the comparable quarter last year, primarily due to higher legal and professional services fees and to increased activities in the U.S. as part of forthcoming clinical trials.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
British lender Lloyds Banking Group Plc. Friday reported higher profit in its first half, benefited by increased net interest income and margin as well as lower impairment. Looking ahead, the company lifted its net interest margin forecast. Amgen reported an increase in second-quarter profit, driven by sales of arthritis drug Enbrel and osteoporosis treatments Xgeva and Prolia, and improved margins. Both earnings and sales topped Wall Street estimates. Electronic Arts Inc. (EA) on Thursday reported an increase in profit for the first quarter, reflecting continued strong digital revenues, with both earnings and revenues topping Wall Street estimates. However, shares of the company fell over 4 percent, after having detailed a weak outlook. Redwood...
comments powered by Disqus
Follow RTT